Orange Book product · Generic (ANDA)
SODIUM BICARBONATE
SODIUM BICARBONATE
At a glance
Nov 09, 2005
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 09, 2005
20 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM BICARBONATE
Strength
44.6MEQ/50ML (0.9MEQ/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
ANDA 077394
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM BICARBONATE
- 1986SODIUM BICARBONATE IN PLASTIC CONTAINERBrand (NDA)
NDA 019443 · ABBOTT
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 220788 · ASPIRO
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 217523 · AMNEAL
- 2025SODIUM BICARBONATEGeneric (ANDA)
ANDA 206688 · FRESENIUS KABI USA
- 2025SODIUM BICARBONATEGeneric (ANDA)
ANDA 219701 · ANTHEA PHARMA
- 2024SODIUM BICARBONATEGeneric (ANDA)
ANDA 216042 · LONG GROVE PHARMS
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 217594 · STERISCIENCE
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 216364 · OMNIVIUM PHARMS
- 2019SODIUM BICARBONATEGeneric (ANDA)
ANDA 211091 · EXELA PHARMA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202432 · HOSPIRA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 203449 · INTL MEDICATION SYS
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202679 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
